Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners
Tetsuhiro Chiba(Chiba University), Osamu Yokosuka(Chiba University)
Cited by 79
Related Papers
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma
|International Journal of Cancer|2014|117
New antiviral therapies for chronic hepatitis C
|Hepatology International|2010|105